search
Back to results

Exercise and Vascular Function in Chronic Kidney Disease

Primary Purpose

Chronic Renal Insufficiency

Status
Completed
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
Aerobic Exercise Training
Sponsored by
University of Delaware
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Chronic Renal Insufficiency focused on measuring Exercise Therapy, Endothelium, vascular, Blood Vessels

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • CKD Exercise and CKD Control Arms: Stage 1 - 4 Chronic Kidney Disease (eGFR 15 - 90 ml/min/1.73m2)
  • Healthy Control Arm: eGFR > 90 ml/min/1.73m2)

Exclusion Criteria:

  • History of cardiovascular disease
  • Uncontrolled hypertension
  • Lung disease
  • Liver disease
  • Cancer
  • Immunosuppressant or antiretroviral therapy
  • Current tobacco use
  • Pregnancy
  • Hormone replacement therapy
  • Unable to give consent

Sites / Locations

  • Department of Kinesiology and Applied Physiology, University of Delaware

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

No Intervention

No Intervention

Arm Label

CKD Aerobic Exercise Training

CKD Control

Healthy Control

Arm Description

Chronic Kidney Disease participants randomly allocated to the CKD Exercise arm will receive 12 weeks of Aerobic Exercise Training three times per week.

Chronic Kidney Disease participants allocated to the the CKD Control arm will receive their standard routine care over a 12 week period.

Healthy participants will act as comparators, they will undergo baseline testing only and will not receive an intervention.

Outcomes

Primary Outcome Measures

Endothelial Function
Conduit artery endothelial function assessed by brachial artery flow mediated dilation; Microvascular endothelial function assessed by cutaneous vasodilation in response to local heating measured by microdialysis and laser Doppler flowmetry.

Secondary Outcome Measures

Microvascular function
Nitric oxide contribution to cutaneous microvascular vasodilation in response to local heating assessed by microdialysis and laser Doppler flowmetry
Oxidative stress contribution to vascular dysfunction
Oxidative stress contribution to cutaneous vasodilation dysfunction in response to local heating assessed by microdialysis and laser Doppler flowmetry.
Endothelial cell oxidative stress
Endothelial cell nitrotyrosine, NADPH oxidase, MnSOD oxidase content obtained from antecubital vein endothelial cells and assessed by fluorescence microscopy.
Plasma Oxidized Low Density Lipoprotein
Plasma oxidized low density lipoprotein measured by ELISA
F2-isoprostanes
Urinary F2-isoprostanes measured by ELISA
Pulse Wave Analysis
Central blood pressure and augmentation index assessed by oscillometry and radial tonometry
Arterial Stiffness
Carotid to femoral pulse wave velocity and assessed by tonometry
Ambulatory Blood Pressure
24 hour blood pressure recorded by oscillometric monitors
Peak Aerobic Capacity
Peak oxygen uptake (VO2peak/max) during incremental cycling exercise until exhaustion
Physical Function
Dexterity by the '9-Hole Peg Test'; Endurance by the '2 Minute Walk Endurance Test'; locomotion by the '4 Meter Gait Speed Test'; isometric handgrip strength test by handgrip dynamometry.
Habitual Physical Activity
Daily average energy expenditure, step count and physical activity intensity level by accelerometry.
Knee Extensor Strength
Maximal isometric knee extensor strength

Full Information

First Posted
January 28, 2014
Last Updated
August 29, 2017
Sponsor
University of Delaware
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
search

1. Study Identification

Unique Protocol Identification Number
NCT02050035
Brief Title
Exercise and Vascular Function in Chronic Kidney Disease
Official Title
Exercise and Vascular Function in Chronic Kidney Disease
Study Type
Interventional

2. Study Status

Record Verification Date
August 2017
Overall Recruitment Status
Completed
Study Start Date
July 2013 (Actual)
Primary Completion Date
July 2017 (Actual)
Study Completion Date
July 31, 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Delaware
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to investigate the effects of 12 weeks of aerobic exercise training on blood vessel function in Stages 1-4 Chronic Kidney Disease.
Detailed Description
The endothelium lines the inside of the blood vessels. A healthy endothelial lining acts as a defense mechanism against vascular injury, mediating vascular tone, vascular structure, and blood-vessel wall relations. Endothelial dysfunction marks the occurrence of cardiovascular injuries and is a critical step in the development of cardiovascular disease. Individuals with Chronic Kidney Disease (CKD) have an increased risk of cardiovascular disease and this may be related to poor blood vessel function. Interventions to improve blood vessel function in CKD are needed. Exercise training has been shown to improve blood vessel function in older subjects and those with heart disease but this has not been investigated in CKD. The National Kidney Foundation recommends exercise for dialysis patients to reduce cardiovascular risk however there is very little data regarding the benefits of exercise in earlier stages of CKD. The purpose of this study is to determine the effect of 12 weeks of exercise training on blood vessel function in moderate to severe CKD.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Renal Insufficiency
Keywords
Exercise Therapy, Endothelium, vascular, Blood Vessels

7. Study Design

Primary Purpose
Basic Science
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
76 (Actual)

8. Arms, Groups, and Interventions

Arm Title
CKD Aerobic Exercise Training
Arm Type
Experimental
Arm Description
Chronic Kidney Disease participants randomly allocated to the CKD Exercise arm will receive 12 weeks of Aerobic Exercise Training three times per week.
Arm Title
CKD Control
Arm Type
No Intervention
Arm Description
Chronic Kidney Disease participants allocated to the the CKD Control arm will receive their standard routine care over a 12 week period.
Arm Title
Healthy Control
Arm Type
No Intervention
Arm Description
Healthy participants will act as comparators, they will undergo baseline testing only and will not receive an intervention.
Intervention Type
Other
Intervention Name(s)
Aerobic Exercise Training
Intervention Description
Supervised outpatient moderate to vigorous aerobic training at 60% - 85% heart rate reserve, carried out for 45 minutes, three times per week over a twelve week period.
Primary Outcome Measure Information:
Title
Endothelial Function
Description
Conduit artery endothelial function assessed by brachial artery flow mediated dilation; Microvascular endothelial function assessed by cutaneous vasodilation in response to local heating measured by microdialysis and laser Doppler flowmetry.
Time Frame
Change from baseline at 12 weeks
Secondary Outcome Measure Information:
Title
Microvascular function
Description
Nitric oxide contribution to cutaneous microvascular vasodilation in response to local heating assessed by microdialysis and laser Doppler flowmetry
Time Frame
Change from baseline at 12 weeks
Title
Oxidative stress contribution to vascular dysfunction
Description
Oxidative stress contribution to cutaneous vasodilation dysfunction in response to local heating assessed by microdialysis and laser Doppler flowmetry.
Time Frame
Change from baseline at 12 weeks
Title
Endothelial cell oxidative stress
Description
Endothelial cell nitrotyrosine, NADPH oxidase, MnSOD oxidase content obtained from antecubital vein endothelial cells and assessed by fluorescence microscopy.
Time Frame
Changes from baseline at 12 weeks
Title
Plasma Oxidized Low Density Lipoprotein
Description
Plasma oxidized low density lipoprotein measured by ELISA
Time Frame
Change from baseline at 12 weeks
Title
F2-isoprostanes
Description
Urinary F2-isoprostanes measured by ELISA
Time Frame
Change from baseline at 12 weeks
Title
Pulse Wave Analysis
Description
Central blood pressure and augmentation index assessed by oscillometry and radial tonometry
Time Frame
Change from baseline at 12 weeks
Title
Arterial Stiffness
Description
Carotid to femoral pulse wave velocity and assessed by tonometry
Time Frame
Change from baseline at 12 weeks
Title
Ambulatory Blood Pressure
Description
24 hour blood pressure recorded by oscillometric monitors
Time Frame
Change from baseline at 12 weeks
Title
Peak Aerobic Capacity
Description
Peak oxygen uptake (VO2peak/max) during incremental cycling exercise until exhaustion
Time Frame
Change from baseline at 12 weeks
Title
Physical Function
Description
Dexterity by the '9-Hole Peg Test'; Endurance by the '2 Minute Walk Endurance Test'; locomotion by the '4 Meter Gait Speed Test'; isometric handgrip strength test by handgrip dynamometry.
Time Frame
Change from baseline at 12 weeks
Title
Habitual Physical Activity
Description
Daily average energy expenditure, step count and physical activity intensity level by accelerometry.
Time Frame
Change from baseline at 12 weeks
Title
Knee Extensor Strength
Description
Maximal isometric knee extensor strength
Time Frame
Change from baseline at 12 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: CKD Exercise and CKD Control Arms: Stage 1 - 4 Chronic Kidney Disease (eGFR 15 - 90 ml/min/1.73m2) Healthy Control Arm: eGFR > 90 ml/min/1.73m2) Exclusion Criteria: History of cardiovascular disease Uncontrolled hypertension Lung disease Liver disease Cancer Immunosuppressant or antiretroviral therapy Current tobacco use Pregnancy Hormone replacement therapy Unable to give consent
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
David Edwards, PhD
Organizational Affiliation
University of Delaware
Official's Role
Principal Investigator
Facility Information:
Facility Name
Department of Kinesiology and Applied Physiology, University of Delaware
City
Newark
State/Province
Delaware
ZIP/Postal Code
19713
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
33316435
Citation
Kirkman DL, Ramick MG, Muth BJ, Stock JM, Townsend RR, Edwards DG. A randomized trial of aerobic exercise in chronic kidney disease: Evidence for blunted cardiopulmonary adaptations. Ann Phys Rehabil Med. 2021 Nov;64(6):101469. doi: 10.1016/j.rehab.2020.101469. Epub 2021 Oct 26.
Results Reference
derived

Learn more about this trial

Exercise and Vascular Function in Chronic Kidney Disease

We'll reach out to this number within 24 hrs